New approach to treating spinal cord injury using PEG-TAT-modified, cyclosporine-A-loaded PLGA/polymeric liposomes

scientific article published on 2 June 2016

New approach to treating spinal cord injury using PEG-TAT-modified, cyclosporine-A-loaded PLGA/polymeric liposomes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/1061186X.2016.1191082
P698PubMed publication ID27250819

P2093author name stringYang Liu
Guang-Zhi Ning
Shi-Qing Feng
Jin Chang
Liang-Liang Wang
De-Xiang Ban
Han-Jie Wang
Shi-Jie Gao
Shi-Zhao Cheng
P2860cites workSelf-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injuryQ24646208
Tight junctions of the blood-brain barrierQ28145432
A sensitive and reliable locomotor rating scale for open field testing in ratsQ29619624
Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injuryQ30513561
Glutathione monoethyl ester improves functional recovery, enhances neuron survival, and stabilizes spinal cord blood flow after spinal cord injury in ratsQ33209748
Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in ratsQ33924997
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devicesQ34072262
Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?Q35968596
Nanoparticles as novel carrier for brain delivery: a reviewQ37411459
Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.Q39738228
Development of a cell transducible RhoA inhibitor TAT-C3 transferase and its encapsulation in biocompatible microspheres to promote survival and enhance regeneration of severed neuronsQ40075520
Cationic TAT peptide transduction domain enters cells by macropinocytosis.Q40470431
Cyclosporine A attenuates hypoxic–ischemic brain injury in newborn ratsQ42927251
Novel multifunctional polyethylene glycol-transactivating-transduction protein-modified liposomes cross the blood-spinal cord barrier after spinal cord injuryQ43232047
Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparingQ43630458
Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrierQ46836311
Acute transplantation of olfactory ensheathing cells or Schwann cells promotes recovery after spinal cord injury in the rat.Q48019673
Immediate damage to the blood-spinal cord barrier due to mechanical traumaQ48220670
Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticlesQ48913327
P433issue1
P304page(s)75-82
P577publication date2016-06-02
P1433published inJournal of Drug TargetingQ6295099
P1476titleNew approach to treating spinal cord injury using PEG-TAT-modified, cyclosporine-A-loaded PLGA/polymeric liposomes
P478volume25

Reverse relations

Q47179205Nischarin-siRNA delivered by polyethylenimine-alginate nanoparticles accelerates motor function recovery after spinal cord injurycites workP2860

Search more.